Leads to Development, Limited Liability Company
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Leads to Development, Limited Liability Company - overview
Established
2009
Location
Paris, -, France
Primary Industry
Pharmaceuticals
About
Based in Paris, France, Leads To Development (L2D) provides nonclinical, CMC, regulatory, and clinical trial oversight consulting services to biotechnology, pharmaceutical, and medical device companies. The company supports clients throughout drug development, from early-stage planning through regulatory submissions and clinical development. Based in Paris, France and founded in 2009, Leads To Development (L2D), founded by Jonathan Kearsey and team, provides nonclinical, CMC, regulatory, quality assurance, and clinical development consulting services for the life sciences industry. In September 2026, Clarenta Group Ltd.
, a portfolio company of Edgecap Partners, acquired a majority stake in Leads to Development, Limited Liability Company. Leads To Development provides nonclinical and CMC development strategy, operational project management, regulatory strategy and submissions, quality assurance/GxP audits, and clinical trial oversight. It also supports regulatory processes involving the EMA and FDA, including IND, CTA, BLA and NDA-related preparation. The company primarily generates revenue by providing specialized consulting and project-management services to biotechnology, pharmaceutical, and medical-device companies.
Revenue is derived from services covering nonclinical/CMC development, regulatory affairs, quality assurance, and clinical trial oversight.
Current Investors
Clarenta Group Ltd.
Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Pharmaceutical Research & Development
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Leads to Development, Limited Liability Company - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Leads to Development, Limited Liability Company | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.